Education
About Us
Working with TipRanks
Follow Us
Adicet Bio (ACET)
NASDAQ:ACET
Total Valuation
Adicet Bio has a market cap or net worth of $105.79M. The enterprise value is -$54.04M.
Market Cap$105.79M
Enterprise Value-$54.04M
Share Statistics
Adicet Bio has 153,254,780 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding153,254,780
Owned by Insiders5.25%
Owned by Institutions<0.01%
Financial Efficiency
Adicet Bio’s return on equity (ROE) is -0.63 and return on invested capital (ROIC) is -61.62%.
Return on Equity (ROE)-0.63
Return on Assets (ROA)-0.53
Return on Invested Capital (ROIC)-61.62%
Return on Capital Employed (ROCE)-0.64
Revenue Per Employee0.00
Profits Per Employee-770.54K
Employee Count152
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Adicet Bio is ―. Adicet Bio’s PEG ratio is 0.01.
PE Ratio―
PS Ratio0.00
PB Ratio0.45
Price to Fair Value0.45
Price to FCF-0.90
Price to Operating Cash Flow-0.64
PEG Ratio0.01
Income Statement
In the last 12 months, Adicet Bio had revenue of 0.00 and earned -117.12M in profits. Earnings per share was -1.33.
Revenue0.00
Gross Profit-6.47M
Operating Income-127.61M
Pretax Income-117.12M
Net Income-117.12M
EBITDA-110.65M
Earnings Per Share (EPS)-1.33
Cash Flow
In the last 12 months, operating cash flow was -98.44M and capital expenditures -1.92M, giving a free cash flow of -100.36M billion.
Operating Cash Flow-98.44M
Free Cash Flow-100.36M
Free Cash Flow per Share-0.65
Dividends & Yields
Adicet Bio pays an annual dividend of $0.01, resulting in a dividend yield of ―
Dividend Per Share$0.01
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.72
52-Week Price Change-48.09%
50-Day Moving Average0.83
200-Day Moving Average0.76
Relative Strength Index (RSI)33.86
Average Volume (3m)1.92M
Important Dates
Adicet Bio upcoming earnings date is Mar 5, 2026, After Close (Confirmed).
Last Earnings DateNov 5, 2025
Next Earnings DateMar 5, 2026
Ex-Dividend DateSep 21, 2018
Financial Position
Adicet Bio as a current ratio of 9.29, with Debt / Equity ratio of 11.52%
Current Ratio9.29
Quick Ratio9.29
Debt to Market Cap0.04
Net Debt to EBITDA0.35
Interest Coverage Ratio-31.90K
Taxes
In the past 12 months, Adicet Bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Adicet Bio EV to EBITDA ratio is -0.41, with an EV/FCF ratio of -0.48.
EV to Sales0.00
EV to EBITDA-0.41
EV to Free Cash Flow-0.48
EV to Operating Cash Flow-0.49
Balance Sheet
Adicet Bio has $29.10M in cash and marketable securities with $15.54M in debt, giving a net cash position of $13.56M billion.
Cash & Marketable Securities$29.10M
Total Debt$15.54M
Net Cash$13.56M
Net Cash Per Share$0.09
Tangible Book Value Per Share$2.12
Margins
Gross margin is -24.88%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin-24.88%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Adicet Bio is $6.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$6.50
Price Target Upside855.88% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast―
EPS Growth Forecast25.89%